ISNCT

Tag: Kato T.

Article Clinical trials Phase II Studies Toxicity Year 2022

Profile analysis of adverse events after boron neutron capture therapy for head and neck cancer: a sub-analysis of the JHN002 study

Post author By ISNCT
Post date May 20, 2022

Journal of Radiation Research, 2022

Tags Hirose K., Journal of Radiation Research, Kato T., Kikuchi Y., Murakami M., Sato M., Seto I., Suzuki M., Takai Y., Takayama K., Yamaguchi H.

Article Clinical trials Phase II Studies Toxicity Year 2021

Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase II study

Post author By ISNCT
Post date May 20, 2022

Neurooncology Advances, 2021

Tags Goto H, Hirose K., Kato T., Kawabata S., Miyatake S., Narita Y, Neurooncology Advances, Suzuki M., Tanaka H.

Article Clinical trials Phase II Studies Toxicity Year 2020

Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial

Post author By ISNCT
Post date May 20, 2022

Radiotherapy and Oncology, 2020

2020 Article BSA designs Dosimetry Physics

Design and construction of an accelerator-based boron neutron capture therapy (AB-BNCT) facility with multiple treatment rooms at the Southern Tohoku BNCT Research Center

Applied Radiation and Isotopes, 2020

Tags Applied Radiation and Isotopes, Arai K., Harada T., Hirose K., Kato R., Kato T., Mitsumoto T., Motoyanagi T., Takai T., Takeuchi A., Tanaka H., Yajima S.